Rheumatoid Arthritis Trial, Recruiting NCT07646262 Sponsor: Hasan Kalyoncu University Condition: Rheumatoid Arthritis
Back to Rheumatoid Arthritis

Rheumatoid Arthritis Trial, Recruiting

NCT07646262
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with rheumatoid arthritis based on recognised international criteria (ACR/EULAR)
  • People aged between 19 and 65 years
  • People whose arthritis medications have remained unchanged for at least 3 months before joining the trial
  • People who are willing to follow specific dietary guidelines and take part in all study activities
  • People who are able to give their formal written agreement to participate

Who may not be able to join:

  • People who are currently pregnant or breastfeeding
  • People who have other conditions where the immune system attacks the body, such as lupus or inflammatory bowel disease
  • People with serious health conditions affecting the heart, kidneys, or liver
  • People who have been following a special diet, such as a gluten-free diet, in the three months before joining
  • People whose biologic therapy or steroid medication has changed within the last three months
  • People with food allergies or intolerances that would make it difficult to follow the trial's dietary plan
  • People who would have difficulty sticking to the required diet or attending follow-up appointments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +90 506 379 73 42

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hasan Kalyoncu University
Registry
ClinicalTrials.gov
Start date
29 October 2025
Est. completion
30 June 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Disease Activity (DAS28)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov